MEDIA
Press Release
https://www.globenewswire.com/news-release/2022/05/10/2439186/0/en/Blue-Note-Therapeutics-and-Bixink-Enter-Licensing-Agreement-for-attune-and-DreAMLand-Prescription-Digital-Therapeutics-for-Mental-Well-Being-in-Cancer-Patients.html
Copyright 2021 - BIXINK │ Terms of Use
Contact │ Privacy
6F, 292 Gangnam-daero, Gangnam-gu, Seoul 06258,
Republic of Korea
6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea [06125]
Copyright 2021 - BIXINK │ Terms of Use │ Contact │ Privacy
6F, 561 Nonhyeon-ro, Gangnam-gu, Seoul 06125, Republic of Korea
https://www.globenewswire.com/news-release/2022/05/10/2439186/0/en/Blue-Note-Therapeutics-and-Bixink-Enter-Licensing-Agreement-for-attune-and-DreAMLand-Prescription-Digital-Therapeutics-for-Mental-Well-Being-in-Cancer-Patients.html